Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy

The ataxia-telangiectasia mutated (ATM) protein plays a central role in DNA damage response and cell cycle checkpoints, and may be a promising target for cancer therapy if normal tissue toxicity could be avoided. Our strategy to target ATM for breast cancer therapy involves the use of liposomal-enca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Xu, Rong, Huang, Yi, Mai, Junhua, Zhang, Guodong, Guo, Xiaojing, Xia, Xiaojun, Koay, Eugene J, Li, Qingpo, Liu, Xuewu, Ferrari, Mauro, Shen, Haifa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3842236/
https://ncbi.nlm.nih.gov/pubmed/23293085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/smll.201201510
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller